• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

Methyl 3-bromo-1H-indole-4-carboxylate (CAS No. 1093759-60-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 3-bromo-1H-indole-4-carboxylate (CAS No. 1093759-60-4) is a highly versatile and significant intermediate in the realm of pharmaceutical chemistry. This compound, characterized by its unique structural features, has garnered considerable attention due to its role in the synthesis of various biologically active molecules. The presence of both bromine and carboxylate functional groups makes it a valuable building block for further chemical modifications, enabling the development of novel therapeutic agents.

The< strong>1H-indole core of this molecule is particularly noteworthy, as indole derivatives are well-documented for their broad spectrum of biological activities. These activities range from antimicrobial and anti-inflammatory properties to more specialized functions such as modulation of neurological pathways. The bromination at the 3-position enhances the reactivity of the indole ring, making it amenable to cross-coupling reactions like Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures.

In recent years, there has been a surge in research focused on developing innovative treatments for neurological disorders. Methyl 3-bromo-1H-indole-4-carboxylate has emerged as a critical precursor in this endeavor. For instance, studies have demonstrated its utility in synthesizing indole-based ligands that interact with serotonin receptors, which are implicated in conditions such as depression and anxiety. The carboxylate moiety allows for further derivatization into amides or esters, expanding its potential applications in drug design.

The pharmaceutical industry has also leveraged this compound in the development of antitumor agents. Researchers have explored its incorporation into molecules that exhibit inhibitory effects on kinases and other enzymes involved in cancer cell proliferation. The bromine substituent facilitates palladium-catalyzed reactions, enabling the construction of polycyclic structures that mimic natural products with potent anticancer properties. Such derivatives have shown promise in preclinical studies, highlighting the importance of Methyl 3-bromo-1H-indole-4-carboxylate as a cornerstone in medicinal chemistry.

Moreover, the compound's role extends beyond oncology. It has been utilized in the synthesis of antimicrobial agents targeting resistant bacterial strains. The indole scaffold is known to disrupt bacterial cell membranes and interfere with vital metabolic pathways. By incorporating Methyl 3-bromo-1H-indole-4-carboxylate into these molecules, chemists have been able to design compounds with enhanced efficacy against pathogens that have evolved resistance to conventional antibiotics.

The synthetic methodologies involving Methyl 3-bromo-1H-indole-4-carboxylate are also worth mentioning. Advances in catalytic systems have enabled more efficient and environmentally friendly routes to this intermediate. For example, recent developments in transition metal catalysis have allowed for the direct bromination of indole derivatives under milder conditions, reducing byproduct formation and improving yields. These innovations align with the growing emphasis on sustainable chemistry practices within the pharmaceutical sector.

In conclusion, Methyl 3-bromo-1H-indole-4-carboxylate (CAS No. 1093759-60-4) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural attributes and reactivity make it an indispensable tool for medicinal chemists seeking to develop novel therapeutics across various disease areas. As research continues to uncover new applications for this compound, its significance is poised to grow even further, solidifying its place as a pivotal intermediate in drug discovery and development.

• 1186663-26-2(3-Bromoindole-4-carboxylic Acid)
• 220844-75-7(Ethyl 8-bromoquinoline-4-carboxylate)
• 101909-43-7(Methyl 4-bromo-1H-indole-3-carboxylate)
• 882679-96-1(Methyl 4-bromo-1H-indole-6-carboxylate)
• 860457-92-7(methyl 3-bromo-1H-indole-6-carboxylate)
• 107650-22-6(Methyl 6-bromo-1H-indole-4-carboxylate)
• 253787-45-0(Methyl 8-Bromoquinoline-5-carboxylate)
• 959239-01-1(Methyl 7-Bromo-1h-indole-3-carboxylate)
• 219508-19-7(3-Bromo-1H-indole-6-carboxylic acid)
• 885523-35-3(Methyl 7-bromo-1H-indole-5-carboxylate)